At the center of the nation’s delta variant outbreak, public health efforts are mired in a political turf war.
Thousands of schools have spent millions of federal covid relief dollars snapping up air cleaning technology that claims to inactivate covid-19. But the devices fall into a regulatory gap.
The technology that schools have been snapping up in the fight against covid “has not shown significant disinfection effectiveness” to install on its planes, Boeing found. Now the company’s study is being debated in a proposed class-action suit.
Black Americans’ vaccination rates still trail all other groups, while Hispanics show improvement. Native Americans show the strongest rates nationally.
A KHN investigation found that more than 2,000 schools have spent millions of dollars for systems, lured by air purifier companies’ claims that experts say mislead or obscure the potential for harm from toxic ozone.
Congress has poured tens of billions of dollars into public health since last year. While health officials who have juggled bare-bones budgets for years are grateful for the money, they worry it will soon dry up, just as it has after previous crises such as 9/11, SARS and Ebola. Meanwhile, they continue to cope with an exodus from the field amid political pressure and exhaustion that meant 1 in 6 Americans lost their local health department leader.
El Congreso ha enviado miles de millones a los departamentos de salud para luchar contra covid. Pero históricamente, esta financiación se acaba cuando termina la emergencia sanitaria.
Dr. Robert Redfield, Trump’s CDC director, lends his scientific credibility to its Clean Air Systems subsidiary, which touts a “virus-killing ion technology” added to its fans. But indoor air quality experts question whether some of its technology works in the real world.
Same building. Same procedure. Same doctor. But now you’re charged a hospital facility fee. For one Ohio Medicare patient, the copay for a shot that used to cost her about $30 went up to more than $300.
Air-cleaning companies with limited oversight are targeting a growing market of schools desperate for covid-19 protection. Donald Trump’s former covid adviser lands with one that built its business, in part, on ozone-emitting technology.